NewcelX partners with Eledon to develop diabetes treatment
Go back to NewcelX partners with Eledon to develop diabetes treatment| (NASDAQ: ELDN) | Delayed: 2.13 -0.14 (6.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.27 | 52 Week High | $ | |||
| Open | $2.27 | 52 Week Low | $ | |||
| Day High | $2.42 | P/E | N/A | |||
| Day Low | $2.13 | EPS | $ | |||
| Volume | 803,247 | |||||
| (NASDAQ: NCEL) | Delayed: 2.50 -0.35 (12.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.85 | 52 Week High | $ | |||
| Open | $2.77 | 52 Week Low | $ | |||
| Day High | $3.14 | P/E | N/A | |||
| Day Low | $2.36 | EPS | $ | |||
| Volume | 23,099 | |||||



